Clinical Trial Update: A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy [Phase 2]

View source ↗

Summary

Phase 2 study in rheumatoid arthritis patients on background methotrexate therapy has completed and posted results by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Investigational Lilly drug (Phase 2)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2017-04-21